GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Laboratories Ltd (BOM:538964) » Definitions » EV-to-Revenue

Mercury Laboratories (BOM:538964) EV-to-Revenue : 1.33 (As of Jun. 09, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mercury Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Mercury Laboratories's enterprise value is ₹1,005.3 Mil. Mercury Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹755.6 Mil. Therefore, Mercury Laboratories's EV-to-Revenue for today is 1.33.

The historical rank and industry rank for Mercury Laboratories's EV-to-Revenue or its related term are showing as below:

BOM:538964' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.12   Med: 1.09   Max: 1.91
Current: 1.34

During the past 11 years, the highest EV-to-Revenue of Mercury Laboratories was 1.91. The lowest was 0.12. And the median was 1.09.

BOM:538964's EV-to-Revenue is ranked better than
69.8% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 2.275 vs BOM:538964: 1.34

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-09), Mercury Laboratories's stock price is ₹861.80. Mercury Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹629.66. Therefore, Mercury Laboratories's PS Ratio for today is 1.37.


Mercury Laboratories EV-to-Revenue Historical Data

The historical data trend for Mercury Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Laboratories EV-to-Revenue Chart

Mercury Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 1.17 1.00 0.91 1.28

Mercury Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 1.30 1.24 1.59 1.28

Competitive Comparison of Mercury Laboratories's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercury Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mercury Laboratories's EV-to-Revenue falls into.



Mercury Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mercury Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1005.272/755.59
=1.33

Mercury Laboratories's current Enterprise Value is ₹1,005.3 Mil.
Mercury Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹755.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mercury Laboratories  (BOM:538964) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mercury Laboratories's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=861.80/629.659
=1.37

Mercury Laboratories's share price for today is ₹861.80.
Mercury Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹629.66.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mercury Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mercury Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mercury Laboratories (BOM:538964) Business Description

Traded in Other Exchanges
N/A
Address
Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016
Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and internationally, of which key revenue is derived from sales made in India.

Mercury Laboratories (BOM:538964) Headlines

No Headlines